Hindu (Free subscription) | 07/21/2009
HYDERABAD: Dr. Reddy’s Laboratories Limited, an emerging global pharmaceutical company, has decided to invest close of $200 million for the development of the two special economic zones sanctioned to it in the State. Land ...
Business Wire (Free subscription) | 07/21/2009
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) today announced its unaudited financial results for the first quarter ended June 30, 2009 under International Financial Reporting
Online Pharmacy (Free subscription) | 07/20/2009
India's Dr. Reddy's Laboratories Ltd. (500124.BY) has received tentative approval from the U.S. Food and Drug Administration to sell generic valacyclovir hydrochloride tablets…
Business Wire (Free subscription) | 07/08/2009
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Limited (NYSE:RDY) today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year
Times of India (Free subscription) | 06/29/2009
You may have heard of pharmaceutical companies diversifying into hospitals, but for Hyderabad-based Dr Reddy’s Laboratories Limited (DRL) a foray into hospitality seems to be par for the course.
Hindu (Free subscription) | 06/15/2009
HYDERABAD: Notwithstanding the economic slowdown, Dr. Reddy’s Laboratories Ltd., recruited 1,300 persons this year, including 350 campus recruits across various disciplines. “For good talent, the market is hot and 350 campus ...
The Telegraph India (Free subscription) | 05/31/2009
Mumbai, May 31: Hyderabad-based Dr Reddy's Laboratories Ltd aims to be among the top five generic companies in the US by 2013, banking on an array of new drugs for which it is seeking permissions from American authorities.
The Telegraph India (Free subscription) | 05/18/2009
Mumbai, May 18 (PTI): Dr Reddy's Laboratories has reported a net profit of Rs 156.17 crore in the quarter ended March 31, 2009, down 3.75 per cent over the year-ago period. DRL had a net profit of Rs 162.26 crore in the corresponding period of 2007-08, the company said in a filing to the Bombay Stock Exchange.
Hindu (Free subscription) | 05/18/2009
HYDERABAD: Dr. Reddy’s Laboratories reported a net loss of Rs. 517 crore for the year ended March 31, 2009. Disclosing the results for the fourth quarter and for the whole of 2008-09 here on Monday, Vice-Chairman and CEO G. V. ...
Daily News Analysis (Free subscription) | 05/18/2009
Dr Reddy's Laboratories saw its bottomline shrink in the quarter and year ended March, dragged down by write-downs on Betapharm
Market Watch (Free subscription) | 05/18/2009
BOSTON (MarketWatch) -- Dr. Reddy's Laboratories led drug stocks higher early Monday as shares of the India-based generic drugmaker soared in the wake of the release of its fiscal 2009 financial report. The Amex Pharmaceutical Index and the Amex Biotechnology Index were both up 0.6% at 250.21 and 619.21, respectively. The Dow Jones Industrial Average advanced about 100 points to 8,365. Shares of Dr....
Business Wire (Free subscription) | 05/18/2009
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) today announced its unaudited financial results for the year ended March 31, 2009 under International Financial Reporting Standards
Medical News Today (Free subscription) | 05/13/2009
Australian drug developer, Alchemia Limited (ASX:ACL), announced that its global manufacturing and U.S. marketing partner Dr Reddy's Laboratories (NYSE:RDY) has received notice of acceptance of its Abbreviated New Drug Application (ANDA) from the United States Food and Drug Administration (FDA) for Fondaparinux Sodium.
Business Wire (Free subscription) | 05/11/2009
BRISBANE, Australia--(BUSINESS WIRE)--Australian drug developer, Alchemia Limited (ASX:ACL), today announced that its global manufacturing and U.S. marketing partner Dr Reddy’s Laboratories (NYSE:RDY) has
Indian Express (Free subscription) | 05/09/2009
Pharmaceutical giant Pfizer is facing a post-grant opposition from Dr Reddy's Laboratories for its anti-smoking drug, Chantix.
Videos